KD Logo

Examining the Potential Price Growth of Axsome Therapeutics Inc (AXSM)

In a filing, Axsome Therapeutics Inc revealed its Chief Operating Officer Jacobson Mark L. unloaded Company’s shares for reported $0.59 million on May 29 ’24. In the deal valued at $74.31 per share,7,910 shares were sold. As a result of this transaction, Jacobson Mark L. now holds 5,783 shares worth roughly $0.46 million.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Then, Coleman Mark sold 5,248 shares, generating $394,333 in total proceeds. Upon selling the shares at $75.14, the Director now owns 14,600 shares.

Before that, Coleman Mark sold 5,249 shares. Axsome Therapeutics Inc shares valued at $394,775 were divested by the Director at a price of $75.21 per share. As a result of the transaction, Coleman Mark now holds 19,848 shares, worth roughly $1.57 million.

Morgan Stanley upgraded its Axsome Therapeutics Inc [AXSM] rating to an Overweight from a an Equal-weight in a research note published on April 29, 2024; the price target was increased to $115 from $90. A number of analysts have revised their coverage, including Robert W. Baird’s analysts, who began to cover the stock in mid March with a ‘”an Outperform”‘ rating. UBS began covering AXSM with “Buy” recommendation on February 06, 2024. RBC Capital Mkts started covering the stock on January 25, 2024. It rated AXSM as “an Outperform”.

Price Performance Review of AXSM

On Tuesday, Axsome Therapeutics Inc [NASDAQ:AXSM] saw its stock fall -2.59% to $78.93. Over the last five days, the stock has lost -0.10%. Axsome Therapeutics Inc shares have fallen nearly -0.83% since the year began. Nevertheless, the stocks have risen 9.84% over the past one year. While a 52-week high of $98.40 was reached on 02/12/24, a 52-week low of $55.02 was recorded on 06/11/24. SMA at 50 days reached $75.16, while 200 days put it at $74.80. A total of 0.41 million shares were traded, compared to the trading of 0.76 million shares in the previous session.

Levels Of Support And Resistance For AXSM Stock

The 24-hour chart illustrates a support level at 78.04, which if violated will result in even more drops to 77.16. On the upside, there is a resistance level at 80.57. A further resistance level may holdings at 82.21. The Relative Strength Index (RSI) on the 14-day chart is 57.20, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 3.26, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 24.42%. Stochastics%K at 89.50% indicates the stock is a selling.

The most recent change occurred on December 13, 2023 when Citigroup began covering the stock and recommended ‘”a Buy”‘ rating along with a $125 price target.

Most Popular